Take our
#AllergyQuiz
Mast cells are a versatile group of cells that exert homeostatic functions, but are also responsible for triggering different mast cell-dependent and mast cell -associated diseases, due to excessive activation and/or proliferation. These disorders do not have a curative therapy, although in recent decades different therapeutical strategies have emerged, aimed not only at conventional treatment for symptom control, but also at controlling mast cell activation, proliferation, signalling, degranulation or survival.
In relation to therapeutical strategies, which of the following does not belong to the mast cell silencing strategy?
Check the correct answer by reading the review by Martin Metz and colleagues:
doi.org/10.1111/all.15850
Options:
A) KIT inhibitors
B) Anti-Singlec-8 monoclonal antibody
C) Anti-Singlec-6 monoclonal antibody
D) CD200R agonist
#Allergy_journal @EAACI_JM
Share your answer in the comment section below. We will post the answer after 3 days.
journalallergy.com